COOPER COMPANIES, INC.

COO 10-Q · Q2 2026
API behind this page

COO Q2 2026 request

Playground key active
Request URL /api/financials?ticker=COO&year=2026&quarter=2
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q2 2026 Q2 2025 YoY
Revenue 1,081.5 1,002.3 +7.9%
Show Product Lines breakouts
Fertility · Coopersurgical Segment 143.8 126.9 +13.3%
Office and surgical · Coopersurgical Segment 214.2 205.8 +4.1%
Sphere, other · Coopervision Segment 358.6 341.2 +5.1%
Toric and multifocal · Coopervision Segment 364.9 328.4 +11.1%
Show Business Segments breakouts
Coopersurgical Segment · Operating Segments 358 332.7 +7.6%
CooperSurgical · Operating Segments 358 332.7 +7.6%
Coopervision Segment · Operating Segments 723.5 669.6 +8.0%
CooperVision · Operating Segments 723.5 669.6 +8.0%
Show Geography breakouts
Europe 341.6 291.9 +17.0%
Rest of world 192.1 195.2 -1.6%
US 547.8 515.2 +6.3%
Cost of Revenue 346.1 323.2 +7.1%
Show Business Segments breakouts
CooperSurgical · Operating Segments 116.7 107.6 +8.5%
CooperVision · Operating Segments 229.4 215.6 +6.4%
Gross Profit 735.4 679.1 +8.3%
Selling, General & Administrative 676.2 399 +69.5%
Show Business Segments breakouts
CooperSurgical · Operating Segments 402.4 136.8 +194.2%
CooperVision · Operating Segments 252.2 236.9 +6.5%
Show Consolidation Items breakouts
Corporate Non Segment 21.6 25.3 -14.6%
Research & Development 42.5 45.5 -6.6%
Show Business Segments breakouts
CooperSurgical · Operating Segments 20.4 19.9 +2.5%
CooperVision · Operating Segments 22.1 25.6 -13.7%
Amortization Of Intangible Assets 47.7 49.8 -4.2%
Show Business Segments breakouts
CooperSurgical · Operating Segments 43.5 44.7 -2.7%
CooperVision · Operating Segments 4.2 5.1 -17.6%
Operating Income -31 184.8 -116.8%
Show Business Segments breakouts
CooperSurgical · Operating Segments -225 23.7 -1049.4%
CooperVision · Operating Segments 215.6 186.4 +15.7%
Show Consolidation Items breakouts
Corporate Non Segment -21.6 -25.3 +14.6%
Interest Expense 20.9 24.2 -13.6%
Other Non-Operating Income (Expense) -3.5 16.1 -121.7%
Income Before Taxes -48.4 144.5 -133.5%
Income Tax Expense (Benefit) 29.5 56.8 -48.1%
Net Income -77.9 87.7 -188.8%
Show Equity Components breakouts
Retained Earnings -77.9 87.7 -188.8%
EPS (Basic) -0.4 0.44 -190.9%
EPS (Diluted) -0.4 0.44 -190.9%
Wtd Avg Shares (Basic) 195 199.9 -2.5%
Wtd Avg Shares (Diluted) 195 200.7 -2.8%
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax 0.4 -19.6 +102.0%
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax -29.6 117.7 -125.1%
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest -107.1 185.8 -157.6%
Non-Operating Income (Expense) -3.5 16.1 -121.7%
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax 4.4 -12.7 +134.6%

Balance Sheet

Balance Sheet
Metric Q2 2026 Q2 2025 YoY
Current Assets
Cash & Cash Equivalents 138.8 116.2 +19.4%
Accounts Receivable 809.2 780.9 +3.6%
Inventory 896.4 880.3 +1.8%
Prepaid Expenses & Other Current Assets 455.4 348.3 +30.7%
Total Current Assets 2,299.8 2,125.7 +8.2%
Non-Current Assets
Goodwill 3,888.5 — —
Deferred Tax Assets 1,994.7 2,141.7 -6.9%
Other Non-Current Assets 672.8 659 +2.1%
Total Assets 12,482.3 — —
Show Business Segments breakouts
CooperSurgical · Operating Segments 4,616 — —
CooperVision · Operating Segments 7,626 — —
Show Consolidation Items breakouts
Corporate Non Segment 240.3 — —
Intangible Assets 1,493.2 — —
Other Assets
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization 2,132.2 1,928.5 +10.6%
Intangible Assets Net Excluding Goodwill 1,494.3 — —
Current Liabilities
Debt Current 598.9 59.8 +901.5%
Accounts Payable 233.3 244.2 -4.5%
Employee Related Liabilities Current 165.9 157.1 +5.6%
Deferred Revenue (Current) 127.9 127.6 +0.2%
Litigation Reserve Current 324.8 — —
Other Liabilities Current 353.9 423.8 -16.5%
Total Current Liabilities 1,804.7 1,012.5 +78.2%
Non-Current Liabilities
Deferred Tax Liabilities 96.4 99.1 -2.7%
Accrued Income Taxes Noncurrent 5.6 17.7 -68.4%
Contract With Customer Liability Noncurrent 208.8 196.4 +6.3%
Other Non-Current Liabilities 266.4 274.2 -2.8%
Total Liabilities 4,243.2 4,125.5 +2.9%
Long-Term Debt 1,859.5 2,523.6 -26.3%
Other Liabilities
Long Term Debt And Capital Lease Obligations 1,861.3 2,525.6 -26.3%
Stockholders' Equity
Common Stock 21.8 21.8 0.0%
Additional Paid-In Capital 1,982.6 1,942.7 +2.1%
Accumulated Other Comprehensive Income -363.2 -392.3 +7.4%
Retained Earnings 7,696.2 7,460.4 +3.2%
Treasury Stock Common Value -1,098.5 -744.7 -47.5%
Total Stockholders' Equity 8,238.9 8,287.9 -0.6%
Minority Interest 0.2 0.2 0.0%
Stockholders Equity Including Portion Attributable To Noncontrolling Interest 8,239.1 8,288.1 -0.6%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment 1.7 -4.9 +134.7%
Accumulated Gain (Loss), Net, Cash Flow Hedge, Before Tax, Parent 18.9 31 -39.0%
Accumulated Gain Loss Net Cash Flow Hedge Parent 14.4 23.3 -38.2%
Accumulated Other Comprehensive Income -363.2 -392.3 +7.4%
Accumulated Translation Adjustment -379.3 -410.7 +7.6%
Additional Paid In Capital 1,982.6 1,942.7 +2.1%
Common Shares 20 20 0.0%
Noncontrolling Interest 0.2 0.2 0.0%
Retained Earnings 7,696.2 7,460.4 +3.2%
Treasury Stock 1.8 1.8 0.0%
Treasury Stock Common -1,098.5 -744.7 -47.5%
Total Liabilities & Equity 12,482.3 12,413.6 +0.6%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q2 2026 YTD Q2 2025 YoY
Operating Activities
Depreciation & Amortization 190.9 183.6 +4.0%
Business Combination Contingent Consideration Arrangements Settlement Amount Of Contingent Consideration Liability -0.5 — —
Increase Decrease In Operating Capital 55.5 -241.2 +123.0%
Deferred Income Taxes 87.1 78.3 +11.2%
Other Non-Cash Items 57.8 74.1 -22.0%
Net Cash from Operations 443.7 286.8 +54.7%
Investing Activities
Capital Expenditures -188.6 -167.5 -12.6%
Payments To Acquire Businesses And Assets Net Of Cash Acquired And Other -4.3 -8.5 +49.4%
Net Cash from Investing -192.9 -176 -9.6%
Financing Activities
Proceeds From Issuance Of Long Term Debt 1,733.1 1,418.9 +22.1%
Repayments Of Long Term Debt -1,780.2 -1,444.1 -23.3%
Payments To Acquire Business Gross Installments -44.5 -47.1 +5.5%
Proceeds From Repayments Of Short Term Debt 2 23.2 -91.4%
Proceeds From Payments Of Share Based Arrangement -28.7 -19.7 -45.7%
Share Repurchases -108 -40.6 -166.0%
Proceeds From Stock Plans 3.9 4.2 -7.1%
Payment For Contingent Consideration Liability Financing Activities -1.3 — —
Net Cash from Financing -223.7 -105.2 -112.6%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 1.3 2.9 -55.2%
Net Change in Cash 28.4 8.5 +234.1%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 139 116.2 +19.6%
Restricted Cash And Cash Equivalents At Carrying Value 0.2 — —

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key